1. Muir Gray JA, Haynes RB, Sackett DL et al (1999) Transferring evidence from research into practice: developing evidence-based clinical policy. ACP J Club 126(2):14–16
2. Ogdie A, Coates LC, Gladman DD (2020) Treatment guidelines in psoriatic arthritis. Rheumatology (Oxford) 59(Suppl 1):i37–i46
3. Ward MM, Fries JF (1998) Trends in antirheumatic medication use among patients with rheumatoid arthritis, 1981–1996. J Rheumatol 25:408–416
4. Galindo-Rodriguez G, Avina-Zubieta JA, Fitzgerald A et al (1997) Variations and trends in the prescribing of initial second line therapy for patients with rheumatoid arthritis. J Rheumatol 24:633–638
5. Abrahamowicz M, Fortin PR, du Berger R et al (1998) The relationship between disease activity and expert physician’s decision to start major treatment in active systemic lupus erythematosus: a decision aid for development of entry criteria for clinical trials. J Rheumatol 25:277–284